Companies / HCT

HOLISTA COLLTECH LIMITED

ASX:HCTHousehold & Personal Products
367.8M shares on issueASX (delayed) · as of 28 July 2026$0.066price · delayed$29.4Mmarket cap · indicative
B
Dilution grade

Share count grew 29% in 24 months; 5 cash raises in 24 months; proposed issue pending

Cash runway13.6 quarters of funding
Share-count growth (24m)28.7%
Raise cadence (24m)5 cash raises
Options & rights overhang2.9% of shares
In-the-money supply0.0% of shares
Pending proposed issuesopen proposed issue (Appendix 3B)

HOLISTA COLLTECH LIMITED’s ordinary share count grew 28.7% between November 2024 and November 2025, to 368M shares. The company raised capital five times in the 24-month window for total proceeds of A$8.0M, most recently a A$371K placement in July 2026. Options and rights on issue could convert into 11M new shares, equal to 2.9% of the current share count, with 0% in the money at the present share price. At the March 2026 quarter the company reported A$2.1M in available cash, representing 13.6 quarters of cover. One proposed securities issue (Appendix 3B) is pending, with an expected issue date in October 2026.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
2.9%
Max option dilution
0.0%
ITM option dilution
3
Raises · last 12 months
13.6 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 367.8M per ASX (delayed) (28 July 2026).
303.0M326.8M350.6MDec 24Sept 25July 26Cash raise · 9 July 2026Cash raise · 30 Oct 2025Cash raise · 29 Oct 2025Cash raise · 17 June 2025Cash raise · 27 Feb 2025

Cash runway

13.6 qtrs
More than four quarters of funding at the recent spend rate.
$2.1M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
11 Nov 20253H · cancellationHCT : ORDINARY FULLY PAID335.0MAppendix 3H
11 Nov 20252A · quoted issueHCT : ORDINARY FULLY PAID367.8MAppendix 2A
16 June 20252A · quoted issueHCT : ORDINARY FULLY PAID335.0MAppendix 2A
30 Apr 20253G · unquotedORDINARY FULLY PAID285.8MAppendix 3G
28 Apr 20253G · unquotedHCT : ORDINARY FULLY PAID285.8MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

5 cash raises in the last 24 months · 3 in the last 12 months

$371k
Placement
9 July 2026 ACTIVE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Join the waitlist

Options & convertible securities

2.9%
Total overhang · of current shares
0.0%
In the money · at current price
10.8M
Potential new shares
—
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

No director dealing notices (Appendix 3Y) on record.
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

16 July 2026Final Payment Made in Settlement of ProImmune Litigation
9 July 2026Proposed issue of securities - HCT
9 July 2026Convertible Loan to Fund Settlement of ProImmune Matter
18 June 2026Acquisition of Industrial Land in Collie
17 June 2026Clarification - Binding JV for Collie Collagen Facility
25 May 2026Results of Meeting
25 May 2026Annual General Meeting Presentation
4 May 2026$PHolista Executes Binding JV for Collie Collagen Facility
28 Apr 2026$PQuarterly Activity and Cashflow Report
24 Apr 2026Annual General Meeting - Notice of Access
24 Apr 2026Notice of Annual General Meeting/Proxy Form
22 Apr 2026$PReinstatement to Quotation
22 Apr 2026$PProImmune Judgement and Settlement
13 Apr 2026$PContinuation of Suspension
9 Apr 2026$PSuspension from Quotation
7 Apr 2026$PTrading Halt
29 Mar 2026Appendix 4G
29 Mar 2026Annual Report to shareholders
26 Feb 2026$PAppendix 4E - Preliminary Final Report
29 Jan 2026$PQuarterly Activity and Cashflow Report

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.